SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-24-148659
Filing Date
2024-05-29
Accepted
2024-05-29 08:55:42
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-1 d839896df1.htm F-1 384314
2 EX-5.1 d839896dex51.htm EX-5.1 50933
3 EX-23.1 d839896dex231.htm EX-23.1 2513
4 EX-23.2 d839896dex232.htm EX-23.2 1977
5 EX-FILING FEES d839896dexfilingfees.htm EX-FILING FEES 31854
6 GRAPHIC g839896g0528201348278.jpg GRAPHIC 7120
7 GRAPHIC g839896g0528201348505.jpg GRAPHIC 3110
8 GRAPHIC g839896g79x61.jpg GRAPHIC 68195
  Complete submission text file 0001193125-24-148659.txt   581272
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-1 | Act: 33 | File No.: 333-279773 | Film No.: 24994165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)